Thiruvananthapuram

30°C

Haze

Enter word or phrase

Look for articles in

Last Updated Wednesday November 25 2020 09:24 AM IST

Nepal asks Patanjali to recall six 'substandard' medicines

Text Size
Your form is submitted successfully.

Recipient's Mail:*

( For more than one recipient, type addresses seperated by comma )

Your Name:*

Your E-mail ID:*

Your Comment:

Enter the letters from image :

Nepal asks Patanjali to recall six 'substandard' medicines

Kathmandu: Nepal's drugs watchdog has asked Ramdev's Patanjali Ayurveda to recall six ayurvedic medicines after they were found to be of "substandard quality" following microbial tests.

The Department of Drug Administration, in a public notice, said six Ayurvedic medical products made by Divya Pharmacy in Uttarakhand, were found to be substandard during inspections at various outlets and tests on specimens.

The medicines which failed the microbial tests are Patanjali's Amla Churna, Divya Gashar Churna, Bahuchi Churna, Triphala Churna, Aswangandha and Adviya Churna, the notice said.

"The batch of medicine which were inspected by the department are found to have contained pathogenic bacteria," an official of the Department told PTI.

Army canteens say no to Patanjali's Amla Juice after it fails lab test

The Nepalese drug authorities have urged the stakeholders not to sell or prescribe the use of these six medicines with immediate effect.

A source at Patanjali Ayurveda Kendra in Kathmandu, the sole distributor of the products in Nepal, said the medicines have not been banned but restriction was imposed on the sale and the use of certain batch of the medicines that failed lab test.

"We will immediately recall the medicines if found substandard," he said.

Earlier too, there were complaints about Patanjali products.

In April, the Canteen Stores Department, the retailing entity selling consumer goods to Indian armed forces, had suspended sale of a batch of Patanjali Ayurveda's Amla Juice after it "failed" to clear a laboratory test.

Your form is submitted successfully.

Recipient's Mail:*

( For more than one recipient, type addresses seperated by comma )

Your Name:*

Your E-mail ID:*

Your Comment:

Enter the letters from image :

Email ID:

User Name:

User Name:

News Letter News Alert
News Letter News Alert